Liver transplantation for patients with early-stage hepatocellular cancer evidently represents an extremely effective treatment as compared to other modalities, at least by one analysis of a cancer database. However, less than one-fourth of the apparently acceptable candidates receive this treatment and African Americans are underrepresented in this group. The cause of these results, however, remains obscure with the need for a more in-depth confirmation of these findings readily apparent.
Division of Transplantation, Tufts-New England Medical Center, Boston, Massachusetts
Reprint requests and correspondence: Richard B. Freeman, M.D., Division of Transplantation, Tufts-New England Medical Center, Box 40, 750 Washington Street, Boston, MA 02111.
Received September 4, 2007; accepted September 12, 2007.